2 years ago

MultiplAI Health Raises $2.7 Million for AI-Powered Blood Screening Tests

  • MultiplAI Health, a London-based biotech diagnostics company, has raised $2.7 million in seed funding led by Zentynel, SF500 and Time Partners

  • The company is developing blood screening tests using RNA Sequencing and Artificial Intelligence to detect complex diseases, including cardiovascular disorders and cancer

  • The investment will help MultiplAI expand its operations in the US and continue developing its AI-powered blood screening tests.

    • Covered on